Andrew K. Balo

1.0k total citations · 1 hit paper
12 papers, 359 citations indexed

About

Andrew K. Balo is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Andrew K. Balo has authored 12 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 8 papers in Genetics. Recurrent topics in Andrew K. Balo's work include Diabetes Management and Research (11 papers), Pancreatic function and diabetes (9 papers) and Diabetes and associated disorders (8 papers). Andrew K. Balo is often cited by papers focused on Diabetes Management and Research (11 papers), Pancreatic function and diabetes (9 papers) and Diabetes and associated disorders (8 papers). Andrew K. Balo collaborates with scholars based in United States. Andrew K. Balo's co-authors include Thomas A. Peyser, Irl B. Hirsch, Bruce A. Buckingham, John Welsh, David A. Price, Mark Kipnes, Jonathan R. Hughes, Sue A. Brown, Jennifer L. Reid and Peter Calhoun and has published in prestigious journals such as Diabetes, Diabetes Technology & Therapeutics and Journal of Diabetes Science and Technology.

In The Last Decade

Andrew K. Balo

12 papers receiving 333 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes

2022 100 citations Satish K. Garg, Mark Kipnes et al. Diabetes Technology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew K. Balo United States	8	295	176	166	37	27	12	359
Erwin S. Budiman United States	7	289 1.0×	175 1.0×	152 0.9×	51 1.4×	36 1.3×	8	363
Jort Kropff Netherlands	8	352 1.2×	256 1.5×	180 1.1×	57 1.5×	45 1.7×	8	432
David Kayne United States	4	306 1.0×	161 0.9×	117 0.7×	43 1.2×	41 1.5×	5	363
Narvada Jugnee United Kingdom	9	364 1.2×	273 1.6×	248 1.5×	64 1.7×	27 1.0×	13	489
J. Pickup United Kingdom	6	405 1.4×	228 1.3×	179 1.1×	28 0.8×	24 0.9×	7	480
Mary Voelmle United States	9	299 1.0×	203 1.2×	155 0.9×	29 0.8×	24 0.9×	10	326
Mei Mei Church United States	9	323 1.1×	235 1.3×	188 1.1×	24 0.6×	19 0.7×	22	384
Christie Beatson United States	9	392 1.3×	249 1.4×	178 1.1×	22 0.6×	12 0.4×	10	443
Lars Krinelke Germany	7	364 1.2×	205 1.2×	166 1.0×	44 1.2×	11 0.4×	8	428
Tomas C. Walker United States	11	272 0.9×	154 0.9×	161 1.0×	25 0.7×	12 0.4×	23	325

Countries citing papers authored by Andrew K. Balo

Since Specialization

Citations

This map shows the geographic impact of Andrew K. Balo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew K. Balo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew K. Balo more than expected).

Fields of papers citing papers by Andrew K. Balo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew K. Balo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew K. Balo. The network helps show where Andrew K. Balo may publish in the future.

Co-authorship network of co-authors of Andrew K. Balo

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew K. Balo. A scholar is included among the top collaborators of Andrew K. Balo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew K. Balo. Andrew K. Balo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Garg, Satish K., Mark Kipnes, Kristin Castorino, et al.. (2022). Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. Diabetes Technology & Therapeutics. 24(6). 373–380. 100 indexed citations breakdown →

2.

Welsh, John, et al.. (2022). Comparisons of Fifth-, Sixth-, and Seventh-Generation Continuous Glucose Monitoring Systems. Journal of Diabetes Science and Technology. 18(1). 143–147. 23 indexed citations

3.

Calhoun, Peter, et al.. (2018). Resistance to Acetaminophen Interference in a Novel Continuous Glucose Monitoring System. Journal of Diabetes Science and Technology. 12(2). 393–396. 44 indexed citations

4.

Welsh, John, et al.. (2018). Performance of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System in Pediatric Participants With Type 1 Diabetes. Journal of Diabetes Science and Technology. 13(2). 254–258. 25 indexed citations

5.

Zhang, Xiaohe, et al.. (2018). Consistent Accuracy over 10 Days with a Factory-Calibrated Continuous Glucose Monitoring System in Children and Adults. Diabetes. 67(Supplement_1). 1 indexed citations

6.

Zhang, Xiaohe, et al.. (2018). Assessing Glucose Trend Accuracy with a Novel Continuous Glucose Monitoring System. Diabetes. 67(Supplement_1). 1 indexed citations

7.

Peyser, Thomas A., et al.. (2017). Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data. Diabetes Technology & Therapeutics. 20(1). 6–16. 66 indexed citations

8.

Balo, Andrew K., et al.. (2017). Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data. Diabetes Technology & Therapeutics. 19(12). 699–706. 6 indexed citations

9.

Welsh, John, et al.. (2017). Stability, Accuracy, and Risk Assessment of a Novel Subcutaneous Glucose Sensor. Diabetes Technology & Therapeutics. 19(3_suppl). S21–S24. 5 indexed citations

10.

Hirsch, Irl B., et al.. (2017). A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas. Diabetes Technology & Therapeutics. 19(3_suppl). S38–S48. 27 indexed citations

11.

Peyser, Thomas A., et al.. (2015). Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System. Diabetes Technology & Therapeutics. 17(8). 548–554. 28 indexed citations

12.

Balo, Andrew K., et al.. (2015). The Accuracy and Efficacy of the Dexcom G4 Platinum Continuous Glucose Monitoring System. Journal of Diabetes Science and Technology. 9(5). 1021–1026. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact